This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Eyes On Washington: Shutdown Briefing – Day 9

Welcome to the Eyes on Washington: Shutdown Briefing. During the federal government shutdown, we will be sharing concise, client-focused updates to help you stay informed on key developments, legislative dynamics and potential impacts to your operations and federal engagement.

United States Healthcare

HK

Holland & Knight

The Telehealth Cliff Has Arrived: What's Changing And What To Watch

On October 1st, certain key telehealth flexibilities created during the COVID-19 public health emergency ("PHE") expired as the government shutdown began.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

HHS-OIG And ASTP Jointly Issue Information Blocking Enforcement Alert

On September 4, 2025, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) and Assistant Secretary for Technology Policy/Office of the National Coordinator...

United States Healthcare

AP

Arnold & Porter

Kashiv BioSciences Omalizumab Biosimilar Application Submitted To FDA, Accepted By EMA

On September 26, Amneal Pharmaceuticals, Inc. announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ADL-018, a proposed biosimilar...

United States Healthcare

GP

Goodwin Procter LLP

TrumpRx: What Pharmacies And Plan Sponsors Need To Know

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Holland & Knight Health Dose: October 7, 2025

United States Healthcare

HK

Holland & Knight

Building For The Future: Key Construction Considerations In Life Science And Healthcare Projects

United States Healthcare

HM

Honigman

The High-Stakes Future Of Healthcare Consolidation And Regulation

United States Healthcare

WS

Winston & Strawn LLP

FDA Launches New ANDA Prioritization Pilot To Support U.S.-Based Generic Manufacturing

United States Healthcare

KM

Katten Muchin Rosenman LLP

Court Rules That CMS Cannot Extrapolate Medicare Advantage Risk Adjustment Audit Results

United States Healthcare

GG

Groom Law Group

DOJ Creates New Enforcement & Affirmative Litigation Branch Within Civil Division

United States Healthcare

WR

Wiley Rein

7 Red Flags That Put Your FDA Submission At Risk And How To Fix Them

United States Healthcare

Moringside

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

United States Healthcare

AM

Alvarez & Marsal

A Pivotal Week For Pharmaceutical Policy: Trump Administration Advances Tariff And Drug Pricing Initiatives

United States Healthcare

M

Mintz

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

Kashiv BioSciences Omalizumab Biosimilar Application Submitted To FDA, Accepted By EMA

On September 26, Amneal Pharmaceuticals, Inc. announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ADL-018, a proposed biosimilar...

United States Healthcare

GP

Goodwin Procter LLP

Biogen Ordered To Pay Genentech $88.3 Million In Past Royalties On Cabilly Patents

On September 30, 2025, the U.S. District Court for the Northern District of California ordered Biogen MA, Inc.

United States IP

GP

Goodwin Procter LLP

Aflibercept BPCIA Multi-District Litigation Updates

The aflibercept multi-district litigation consists of multiple actions consolidated in the Northern District of West Virginia, with Regeneron Pharmaceuticals, Inc. ("Regeneron") filing suit under the Biologics...

United States Healthcare

GP

Goodwin Procter LLP

The Continued Rise Of Royalty Deals In Life Sciences

United States Healthcare

GP

Goodwin Procter LLP

Key Considerations For Food Safety Recalls

United States Healthcare

SJ

Steptoe LLP

FDA Seeks Stakeholder Feedback On AI-Enabled Medical Device Performance

United States Healthcare

KM

Katten Muchin Rosenman LLP

Non-binding Guidance: The Administration's Focus On Direct-to-Consumer Prescription Drug Advertising (Podcast)

United States Media & IT

RG

Ropes & Gray LLP

FDA Seeks Input On Real-World Performance Of AI-Enabled Medical Devices: What Biotech And MedTech Innovators Need To Know

United States Healthcare

CM

Crowell & Moring LLP

Podcast - Part I: Going From Young Associate To Veteran Lawyer

United States Litigation

HK

Holland & Knight

See more

Food and Drugs Law

In Antitrust Settlement, California Imposes Unprecedented Controls On Private Equity Purchase Of Walgreens

In an unprecedented antitrust action, the California Attorney General (AG) has intervened in a transaction that did little more than change the ownership of Walgreens Boots Alliance (Walgreens) to a private equity firm...

United States Anti-trust

BB

Baker Botts LLP

Kashiv BioSciences Omalizumab Biosimilar Application Submitted To FDA, Accepted By EMA

On September 26, Amneal Pharmaceuticals, Inc. announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ADL-018, a proposed biosimilar...

United States Healthcare

GP

Goodwin Procter LLP

TrumpRx: What Pharmacies And Plan Sponsors Need To Know

Last week, the Trump administration unveiled a new drug pricing initiative, widely referred to as "TrumpRx." At its core, TrumpRx—which is to be available through...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FDA Launches New ANDA Prioritization Pilot To Support U.S.-Based Generic Manufacturing

United States Healthcare

KM

Katten Muchin Rosenman LLP

DOJ Creates New Enforcement & Affirmative Litigation Branch Within Civil Division

United States Healthcare

WR

Wiley Rein

7 Red Flags That Put Your FDA Submission At Risk And How To Fix Them

United States Healthcare

Moringside

Second Circuit Clarifies Fraud Intent, Restitution, And Forfeiture In Racehorse PED Case

United States Criminal

SJ

Steptoe LLP

Wiley Consumer Protection Download (October 7, 2025)

United States Consumer

WR

Wiley Rein

A Pivotal Week For Pharmaceutical Policy: Trump Administration Advances Tariff And Drug Pricing Initiatives

United States Healthcare

M

Mintz

See more

Healthcare

In Antitrust Settlement, California Imposes Unprecedented Controls On Private Equity Purchase Of Walgreens

In an unprecedented antitrust action, the California Attorney General (AG) has intervened in a transaction that did little more than change the ownership of Walgreens Boots Alliance (Walgreens) to a private equity firm...

United States Anti-trust

BB

Baker Botts LLP

Eyes On Washington: Shutdown Briefing – Day 9

Welcome to the Eyes on Washington: Shutdown Briefing. During the federal government shutdown, we will be sharing concise, client-focused updates to help you stay informed on key developments, legislative dynamics and potential impacts to your operations and federal engagement.

United States Healthcare

HK

Holland & Knight

FTC Abandons Nationwide Noncompete Ban And Pivots To Case-By-Case Enforcement Actions

Ended its multi-year effort to broadly ban employee noncompete agreements by taking steps to dismiss appeals of lower court decisions enjoining its final rule that would have prohibited most employee noncompetes nationwide...

United States Employment

OG

Outside GC

The Telehealth Cliff Has Arrived: What's Changing And What To Watch

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

HHS-OIG And ASTP Jointly Issue Information Blocking Enforcement Alert

United States Healthcare

AP

Arnold & Porter

Health Plans, Courts Struggle With Transgender Healthcare Access

United States Employment

HB

Hall Benefits Law

California Governor Signs Bill Codifying Existing Corporate Practice Restrictions And Imposing Certain New Limitations On Noncompetition Restrictions

United States Commercial

GP

Goodwin Procter LLP

What Clinical Labs Should Know As Pursuit Of Healthcare Fraud Accelerates

United States Criminal

BT

Barnes & Thornburg LLP

Holland & Knight Health Dose: October 7, 2025

United States Healthcare

HK

Holland & Knight

See more

Latest Videos

See more

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Inside MedTech Translation Challenges: Ensuring Multilingual Regulatory Compliance

Moringside

Client Conversations With Patrick Krill (Video)

KG

K&L Gates LLP

Navigating FDA Compliance And Civil Litigation: Strategies For Food And Medical Product Companies (Video)

AP

Arnold & Porter

Upcoming Events

Sharma And Sher To Speak At Demy-Colton’s BioFuture 2025 Conference

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

OUTbio & LGBT+VC: Fall Mixer At Foley Hoag

United States Healthcare

FH

Foley Hoag LLP

ACI’s Inaugural Summit On Pharma And Biotech Patent Litigation – USA

United States Healthcare

GP

Goodwin Procter LLP

15th Annual Health Care Investors Conference

United States Healthcare

BB

Bass, Berry & Sims

Introduction To Advertising And Promotion For Medical Products 2025

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

United States Healthcare

FH

Foley Hoag LLP

LES USA-Canada 2025 Annual Meeting

United States Healthcare

FH

Foley Hoag LLP

Strategic Insights For Navigating Skin Substitute Enforcement

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More